Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
All LSBio Custom kits have been predesigned and all necessary components, including antibodies and standards have been identified. Upon receiving a custom kit order, the kit will be assembled and quality control tested before being shipped out. Kit assembly and testing typically takes 4 to 6 weeks. In most cases the final kit is based on the Sandwich assay principle, with a few being Competitive EIA based. Specifications such as Range, Sensitivity, and Precision are defined upon completion. In the event that the custom kit cannot be successfully developed with 6 weeks of the order date, the customer will be notified and the order canceled at no cost.
LS-F17943 is a 96-well enzyme-linked immunosorbent assay (ELISA) for the detection of Rat ZMAT3. It is based upon a Custom assay principle.
ZMAT3 ElisaKit, PAG608 ElisaKit, Zinc finger protein WIG-1 ElisaKit, WIG-1 ElisaKit, WIG-1/PAG608 protein ElisaKit, Zinc finger protein WIG1 ElisaKit, WIG1 ElisaKit, Zinc finger, matrin type 3 ElisaKit, Zinc finger, matrin-type 3 ElisaKit, p53 target zinc finger protein ElisaKit, p53-activated gene 608 protein ElisaKit
ZMAT3 is a protein containing three zinc finger domains and a nuclear localization signal. The mRNA and the protein of this gene are upregulated by wildtype p53 and overexpression of this gene inhibits tumor cell growth, suggesting that this gene may have a role in the p53-dependent growth regulatory pathway. Alternative splicing of this gene results in two transcript variants encoding two isoforms differing in only one amino acid.